Endovascular treatment of intractable epistaxis - results of a 4-year local audit by Duncan, I C et al.
ORIGINAL ARTICLES
Epistaxis is a common condition affecting an estimated 60% of
the general population, of whom approximately 6% will seek
or require medical assistance.1 Refractory or intractable
epistaxis is defined as recurrent or persistent bleeding after
appropriate conservative treatment, or multiple episodes of
epistaxis over a short period of time, both requiring medical
attention.2 Intractable epistaxis usually arises from the posterior
or superior parts of the nasal cavity, and is therefore not readily
controlled by direct pressure, topical cauterisation or anterior
nasal packing.  Arterial ligation has remained the mainstay of
treatment for intractable posterior epistaxis in many centres.3
Percutaneous embolisation of the internal maxillary artery in
patients with nasal haemorrhage was first described by
Sokoloff et al.4 in 1974.  Currently, endovascular embolisation is
an accepted method of treatment for haemorrhage from the
nasal cavity or other craniofacial lesions.5-7
Materials and methods 
A retrospective audit was done of 57 percutaneous
endovascular embolisation procedures in 51 patients
performed over the 4-year period between July 1999 and June
2003 at the Unitas Interventional Unit in Centurion.  All
patients were referred by an otorhinolaryngologist (ENT
specialist) after failed conventional treatment, generally
involving local cauterisation and/or nasal packing.  Twelve of
our patients had also received a blood transfusion before
embolisation.  We reviewed our procedural data notes, with
further clinical data obtained either from initial referral letters
or from follow-up notes provided by referring clinicians.
Long-term telephonic follow-up was obtained for 38 patients
(respondents). Thirteen patients were untraceable during the
period of the audit.  Of the 38 respondents, 2 had died of
unrelated causes since the embolisation; telephonic interviews
were conducted with the remaining 36.  The collection of data
was flawed by incomplete clinical record keeping.  The most
complete data obtained were for the 36 respondents, as much
of the recorded data could be cross-checked and they could
also provide missing information in addition to long-term
follow-up.  The long-term follow-up period varied between 1
and 47 months.  
All embolisation procedures were performed using a Phillips
V5000 Integris digital monoplane angiography unit.  Initial
diagnostic arteriograms of the internal carotid artery (ICA) and
external carotid artery (ECA) were obtained on each side.  The
ICA was examined in order to exclude an intracranial
aneurysm, arteriovenous shunt or frontal tumour as a possible
cause of the bleeding as well as to identify any arterial supply
to the nasal cavity from ethmoidal branches of each ophthalmic
artery (Fig. 1).  The ipsilateral internal maxillary artery (IMAX),
defined as that supplying the nasal cavity from which the
bleeding was visualised or assumed to arise, was then
superselectively catheterised using a microcatheter technique
and embolised in all cases bar one. In the latter case ipsilateral
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Objective. Transcatheter embolisation is an accepted and
effective treatment for intractable epistaxis. We analysed our
success and complication rates and compared these with
results from other published series.
Design. Retrospective review.
Setting. Unitas Interventional Unit, Centurion.
Methods. Case record review (57 procedures) and telephonic
interviews (36 traceable respondents). 
Outcome measures. A numerical audit of the success and
complication rates for embolisation procedures performed
during the 4-year period between July 1999 and June 2003.
Results. A total of 57 endovascular embolisation procedures
were performed for intractable epistaxis in 51 patients during
this period. Eight patients (15.7%) developed a re-bleed
between 1 and 33 days after embolisation, of whom 5 were re-
embolised, giving a primary short-term success rate of 86.3%
and secondary assisted success rate of 94.1%. Thirty-five of 36
respondents (97.2%) reported no further epistaxis during the
long-term follow-up period of 1 - 47 months. The mortality
rate was 0%, the major morbidity rate was 2% (1 stroke) and
the minor morbidity rate was 25%.
Conclusion. Our success and complication rates are acceptable
and compare favourably with those reported in other large
series.
S Afr Med J 2004; 94: 373-378.
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ECA origin was occluded due to atheromatous disease and  a
contralateral IMAX embolisation was performed.  Other
vessels superselectively catheterised and embolised included
the ipsilateral facial artery (N = 29, 51%), the contralateral
IMAX (N = 27, 47.4%) the contralateral facial artery (N = 8,
14%), the ascending pharyngeal artery (N = 1, 1.7%) and the
accessory meningeal artery (N = 1, 1.7%).  The decision to
embolise arteries other than the ipsilateral IMAX was based on
the relative contributions of each vessel to the supply of the
nasal cavity as well as the potential for collateral supply to the
nasal cavity (Fig. 2). During arteriography the actual site of the
bleeding usually cannot be identified and often no abnormal
vessels are seen in the nasal cavities, although in several cases
a nonspecific generalised nasal mucosal ‘blush’ due to nasal
mucosal congestion or arterial tortuosity may be seen (Figs 2b -
2d).  The most frequently used embolic agents were
microparticles in 56 procedures (98.2%) with particle sizes
ranging from 150 to 700 µm in diameter, usually between 250
and 500 µm.  Other embolic materials used included
cyanoacrylate  (N = 5, 8.8%), platinum microcoils (N = 4, 7%)
and gelatine sponge (Spongistan) (N = 4, 7%).   In all cases
where no macroscopic cause of the bleeding such as a
pseudoaneurysm could be identified, and where micro-
particulate embolisation was performed, the desired endpoint
of embolisation was a significant visible reduction or cessation
of flow in the target vessel(s) (Fig. 3).  Where documented the
nasal packing was removed in theatre in 56% of cases and
afterwards in 44% of cases (N = 36).
Results 
The male-to-female ratio of our patients was 1.2: 1(28 men and
23 women), and the mean age was 54.4 years (range: 17 - 83
Fig. 1. Selective internal carotid digital subtraction arteriogram
showing supply to the superior nasal cavity via the ethmoidal
branches (black arrows) of the ophthalmic artery (white arrow).
Fig. 2a. Selective external carotid digital subtraction arteriogram
showing the arterial supply to the nasal cavity via terminal branches
of the internal maxillary artery (black arrow) and facial artery (white
arrow).
Fig. 2b. Selective internal maxillary arteriogram (same case as
Fig. 2a) showing the typical appearance of the nasal arteries before
embolisation. No bleeding site is identifiable and the arteries have a
normal appearance.
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years). Thirty-two cases (63%) were referred between the
months of May and September. The causes of epistaxis were
deemed idiopathic in 45 (88.2%), related to trauma in 3 (5.9%),
post-surgical in 2 (3.9%) and hereditary haemorrhagic
telangiectasia (HHT) in 1 (2%). Of the 2 cases related to
previous surgery, 1 had recently undergone removal of an
osteoma from the sphenoid sinus (with ipsilateral IMAX
occlusion seen at angiographic examination), while the second
presented with severe bleeding from a large pseudoaneurysm
of the distal IMAX following a recent maxillary osteotomy.
Identifiable risk factors among the respondent group (N = 36)
included hypertension in 19 (52.8%), smoking in 9 (25%),
anticoagulation/antiplatelet use in 5 (13.9%) and radiation
therapy in 1 (2.8%).  None of the respondents volunteered any
history of alcohol or illicit drug abuse. One patient had
previously undergone radiation therapy for a maxillary
malignancy deemed inactive at the time of the embolisation.
One of the non-respondents developed severe epistaxis at 25
weeks of pregnancy for which no underlying cause was found.
One 17-year-old girl with a sideroblastic anaemia for which she
had received multiple blood transfusions over a period of
several years was referred for a semi-elective procedure, the
only case in our series not treated on an emergency basis.
Eight patients (15.7%) developed a re-bleed between 1 and 33
days after the initial embolisation (Table I). Of these, 4 patients
(7.8%) underwent a second embolisation procedure and 1
patient with HHT underwent 2 further embolisation
procedures in our unit and 1 at another centre.  Two patients
(3.9%) underwent additional surgical ligation of the ethmoid
arteries after which no further bleeding was encountered. One
of these had a Le Fort II fracture whereas the second had an
idiopathic-type bleed.  One patient had a single post-
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Fig. 2c. In some cases a prominent nasal capillary blush may be seen
in keeping with mucosal congestion.
Fig. 2d. In others tortuosity of the intranasal arteries may be seen.
Fig. 3. In the same case as shown in Figs 2a and 2b, a selective
internal maxillary arteriogram following microparticulate
embolisation shows very little contrast opacification of the nasal
branches, indicating a satisfactory angiographical endpoint for
embolisation.
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procedural re-bleed; angiographic examination was repeated
but no further embolisation performed.  Therefore, 44 patients
(86.3%) responded well to a single embolisation procedure. No
further re-bleeds were noted in the 4 patients who underwent a
second embolisation procedure, giving a cumulative success
rate for embolisation alone of 94.1%.  With the exception of the
HHT patient, none of the 36 respondents reported a late re-
bleed after primary or secondary intervention.  There was a 0%
mortality rate in our series.  There was a single major
complication (2%), namely the development of a right-sided
cerebral infarction during attempted replacement of a guiding
catheter in a tortuous carotid artery. Minor complications
included transient headache in 3 patients (8.3%), transient
facial pain or paraesthesia in 2 (5.5%) and local groin
haematoma, pain or prolonged anaesthesia in 4 (11%). The total
minor complication rate among the respondent group was
therefore 25%.
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Table I. Re-bleeding after initial embolisation
Age
Patient (years) Risk factors Time of re-bleed Cause of re-bleed Further treatment Outcome
1 34 Smoker 2 days Unknown Repeat angiogram only No re-bleed
2 58 Smoker Multiple re-bleeds HHT Total of 3 embolisations Eventually well
HHT over many years performed (+1 at another palliated for 
centre) in 2 years > 1 year with 
intralesional
bleomycin
3 50 Warfarin and 1/2 day Unknown. Repeat embolisation No re-bleed
Disprin (cardiac The PI at time of the of ipsilateral IMAX
valve replacement) rebleed was 75% only with microparticles
4 25 Pregnant (25 weeks) 33 days Unknown Repeat embolisation of No re-bleed
ipsilateral IMAX only 
with microparticles
5 83 Warfarin (pulmo- 1 day Significant collateral Repeat embolisation of No re-bleed
nary embolism), PI supply via accessory ipsilateral IMAX and acces-
on admission of 34% meningeal artery sory meningeal artery
6 36 Le Fort II fracture 2 days Significant collateral Surgical ligation of No re-bleed
supply via ethmoid ethmoid arteries
arteries
7 55 Hypertension 1/2 day Significant collateral Surgical ligation of No re-bleed
supply via ethmoid ethmoid arteries
arteries
8 18 Maxillary osteotomy 10 days Coil migration and Repeat embolisation No re-bleed
with IMAX pseudo- recannalisation through using particles, coils
aneurysm coils inserted previously and cyanoacrylate
in the IMAX
HHT = hereditary haemorrhagic telangiectasia; PI = prothrombin index; IMAX = internal maxillary artery.
Table II. Reported success and complication rates since 1995 (N (%))
Overall 
Study No. of patients Success rate Minor complications Major complications complication
Elahi et al.,17 57 52 (96) None reported 3 (6) 3 (6)
1995 
Tseng et al.,2 114 101 (88) 17 (15) 2 (1.8) 19 (16.8)
1998  
Leppanen et al.,15 37 33 (89) 4 (8) 0 (0) 4 (8)
1999 
Oguni et al.,18 37 35 (94.6) 7 (45) 0 (0) 7 (45)
2000 
Total 245 221 (90.2) 28 (11.4) 5 (2) 33 (13.4)
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Discussion 
Most cases of epistaxis occur in the anterior nasal cavity in the
region of the anteroinferior septum known as Little's area.
Underlying this is a confluence of arterial territories, namely
those of the sphenopalatine artery, the greater palatine artery,
the facial artery and the anterior and posterior ethmoidal
arteries. This arterial confluence is known as Kiesselbach's
plexus.8 Anterior epistaxis is usually easily controlled by
conservative measures including localised pressure, topical
cauterisation and vasoconstriction, local infiltration with
antifibrinolytic agents and anterior nasal packing.9 Posterior
(and to a lesser degree superior) epistaxis accounts for about
5% of all epistaxis cases and can be extremely difficult to
manage. Posterior nasal packing can be done using gauze or
balloon catheters.  Nasal packing has a reported failure rate of
26 - 52% and a complication rate of 69%.  These complications
include nasal trauma, vasovagal response, aspiration,
displacement of the packing, persistent bleeding, infection,
toxic shock syndrome and hypoxia.9, 10 Surgical approaches
include transantral ligation of the distal IMAX and ligation of
the ethmoid arteries for superior epistaxis.3 More recently,
endoscopic cauterisation and arterial ligation techniques have
been described although these are technically more
demanding.11 The endovascular management of epistaxis has
become an established alternative to surgical ligation.  In a
comparison of efficacy between transantral ligation and
embolisation in intractable epistaxis, Strong et al.12 reported
success rates from the literature of 85% and 90% and average
complication rates of 28% and 27% respectively for ligation and
embolisation, with success rates of 89% and 94% respectively
from their own series.  Cullen and Tami13 showed a failure rate
of 21% for embolisation versus 27% for ligation (with or
without ethmoid ligation) and an overall complication rate of
16% for embolisation and 18% for IMAX ligation.  In their
review of the literature, which expanded upon that by Strong et
al., they reported a slightly higher failure rate for embolisation
(20%) than for IMAX ligation (18%) but a significantly higher
complication rate for IMAX ligation (26%) than for
embolisation (14%).  No difference in major complication rates
(5% v. 4%) was noted between the two methods.
The goal of embolisation is simply to reduce the arterial
pressure head to the affected region without causing any
ischaemic damage to the nasal soft tissues.7 This in turn allows
the body to heal itself.  The posterior nasal cavity is supplied
mainly via the sphenopalatine artery and greater palatine
artery, both being terminal branches of the IMAX. This means
that the management of posterior epistaxis largely hinges
around control of the sphenopalatine artery.  This also explains
the equally high rate of success of ipsilateral IMAX
embolisation alone.  However, there is still a failure rate of 10 -
15% for both embolisation and IMAX/sphenopalatine ligation.
Furthermore, as shown by Vitek,5 the technical success rate of
embolisation increases significantly when additional
embolisation of the ipsilateral facial and contralateral IMAX
arteries is performed as well.   This attests to the importance of
collateral vessels in the facial region with collateral blood
supply to the posterior nasal cavity, which probably accounts
for a significant percentage of failed IMAX ligation and
embolisation procedures.14 The advantage of arteriography is
that it can often identify these collateral sources allowing them
to be treated simultaneously as well. Over 50% of our cases
involved multiple vessel embolisation. Collateral supply to the
nasal cavity leading to recurrent haemorrhage occurred in 4 of
our cases (Table I). Collateral supply via the ethmoid arteries
led to secondary surgical intervention in 2 cases. Another
potential complication related to collateral circulation is the
presence of intracranial-extracranial arterial anastomoses
where inadvertent embolisation through these pathways can
lead to ophthalmologic or neurological complications.6 It is
therefore vital to identify these communications during the
initial angiographic investigation.  Two of our cases with a re-
bleed following initial embolisation of the ipsilateral IMAX
underwent a second procedure involving a repeat
microparticulate embolisation of the same vessel, with good
outcome.  Inadequate embolisation, as with incomplete IMAX
ligation, can therefore lead to recurrent bleeding.  One patient
who had a re-bleed 2 days after embolisation underwent a
repeat arteriogram which showed adequate occlusion of the
ipsilateral distal IMAX branches.  No significant collateral
vessels were identified and so no further embolisation was
performed. No further bleeding was experienced thereafter.
False re-bleeds following embolisation may occasionally be
encountered and may be due to retained blood in and around
the nasal packing or blood draining from the paranasal sinuses.
We used microcatheter techniques in all cases but 1.
Although leading to increased expense and procedural
duration and complexity, the use of microcatheters has been
reported in reducing the number of local cranial complications,
although to date this has not been proved in any randomised
study.15,16 In Table II we reviewed 4 studies conducted in or
after 1995, where the routine use of microcatheter techniques
was reported.  Here we calculated the cumulative success rate
of 90.2% and overall complication rate of 13.4% (11.4% minor
and 2% major) with microcatheter usage. Therefore although
the use of microcatheter techniques does not improve the
overall success rate, there is a tendency towards a lesser
complication rate. This factor should be weighed up against the
additional procedural costs involved per case. Using
microcatheters we have noted a lesser frequency of arterial
vasospasm that can also prolong and complicate a procedure.
One problem that is apparent in the series reported to date is
inconsistency in the reporting of minor and major
complications and hence variation in the reported figures.
Other factors such as improvements in catheter and guidewire
design and increased operator experience have also probably
contributed to the reduction in complication rates in more
recent times.  
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Other complications related to embolisation for epistaxis that
have been reported in other local institutions include ischaemic
necrosis of the upper lip (facial arterial embolisation), unilateral
trismus (related to deep temporal arterial occlusion) and
ischaemic sialadenitis (facial artery embolisation). Further
complications described in the literature include facial nerve
paralysis, tongue necrosis, tonsillar ulceration, facial atrophy
and transient submandibular gland swelling.  Other potential
complications can be related to the femoral access (pain,
bruising, pseudoaneurysm or arteriovenous fistula) or to the
use of contrast media (allergic reaction, renal failure).  Our
single major complication was a stroke related to attempted
replacement of a guiding catheter in an extremely tortuous
carotid artery.  
One advantage of endovascular treatment is that it can be
performed under local anaesthesia with sedation if required.
Although only 38.6% of our cases were performed under
general anaesthesia, our accumulated experience has now led
us to utilise general anaesthesia routinely for 2 reasons.  Firstly,
these patients are generally uncomfortable, with nasal packing
in situ and occasionally active bleeding during the procedure as
well.  Prolonged immobilisation on the angiography table may
be required during difficult cases.  This results in further
patient discomfort and reduced co-operation, with movement
(voluntary and involuntary) rendering the use of electronic
vascular roadmapping useless, further prolonging the
procedure and adding to the risk of complications or an
incomplete or inadequate procedure.  Secondly, we now insist
on full airway protection by means of a cuffed endotracheal
tube before commencing any embolisation procedure in the
head and neck region, where active bleeding is an issue.
Regardless of whether or not a general anaesthetic is
administered, an anaesthetist is always present for patient
monitoring and administration of analgesic or sedative drugs
as required. 
One subgroup of patients who develop recurrent epistaxis
are those with HHT (Osler-Weber-Rendu disease), a genetic
multisystemic angiodysplasia.  These patients develop fragile
nasal mucosal telangiectasias and are prone to repeated and
intractable epistaxis in more than 90% of cases. Embolisation is
not a definitive treatment for epistaxis in these patients but can
control an acute bleeding episode. Because of the known
propensity for epistaxis to recur in these patients, Elden et al.16
found that their long-term success rate for embolisation
increased from 82% to 90% once the HHT patients in their
series were excluded. There is still no definitive treatment
available for the nasal manifestations of HHT.  We have
successfully palliated our patient for more than 18 months
using intramucosal injections of bleomycin (unpublished data).
Although embolisation is a good alternative to surgical
IMAX ligation (or related procedures), interventional expertise
is only available in the major centres in South Africa.  Fifteen
patients were referred from within the Pretoria area, with 36
others being transferred from other centres, generally from
within a 150 km radius of our unit.  In their study of the
attitudes of practising otorhinolaryngologists in Ohio, Cullen
and Tami13 found that before publication of their article in 1998,
only 16% had referred patients for embolisation, of whom
three-quarters were from urban practices and the rest from
rural areas.  Also, more urban than rural hospitals had
embolisation facilities. This finding is mirrored and
undoubtedly amplified in South Africa. In their comparison of
the cost of IMAX ligation versus that of embolisation, Strong et
al.12 found the average cost per case in 1994 for antral ligation
to be US$5 941 versus US$6 783 for embolisation.  Cullen and
Tami13 calculated the average costs in their institution in 1998 to
be US$6 184.55 for IMAX ligation and US$4 544.85 for
embolisation. No comparative figures are available locally.
In conclusion, intractable epistaxis is a debilitating condition
and treatment can be extremely difficult. Percutaneous
transcatheter embolisation of the nasal arteries is an accepted
alternative to surgical intervention, with comparable major and
minor complication rates, success rates and overall costs.
Most cases will respond well to a single embolisation
procedure, with approximately 10% failing to respond owing
to factors such as collateral arterial supply, HHT, etc.  These
procedures should only be performed by suitably experienced
interventional radiologists either under general anaesthesia or
at least with full monitoring and anaesthetic backing.
Thanks to Lizl Geldenhuis for her assistance with preparation of
this manuscript.
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